Federal Register #2026-17112

CMS Requests Public Comment on Proposed Information Collection Activities

CMS, part of the Department of Health and Human Services, is seeking public comment on proposed revisions to its information collection activities. - Government Buyer: - Centers for Medicare & Medicaid Services (CMS) - Department of Health and Human Services - OEMs and Vendors Mentioned: - CMS (as the agency collecting information) - Pharmaceutical manufacturers participating in Medicare Part B drug programs - Products/Services Requested: - No physical products or purchase quantities requested - Information collection and reporting from: - State Medicaid agencies - Managed care organizations - Pharmaceutical manufacturers - Programs covered: - Medicaid Drug Use Review (DUR) Program - Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals - Unique or Notable Requirements: - Annual and quarterly reporting - Compliance with federal regulations - Efforts to minimize information collection burden through automation or technology - Public input sought on burden estimates and process improvements

Description

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. This notice is published under the Paperwork Reduction Act of 1995 (PRA) which requires federal agencies to allow 60 days for public comment on proposed collections of information. The information collection includes revisions to currently approved collections such as the Medicaid Drug Use Review (DUR) Program and Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals. The public is invited to comment on burden estimates, necessity, utility, and ways to minimize the information collection burden through automation or other means.

View original listing